Aetion, A Datavant Company

Aetion, A Datavant Company company information, Employees & Contact Information

Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.

Company Details

Employees
253
Founded
-
Address
5 Penn Plaza,
Phone
646-202-9767
Email
ae****@****ers.com
Industry
Software Development
NAICS
Software Publishers
Website
aetion.com
HQ
New York, NY
Looking for a particular Aetion, A Datavant Company employee's phone or email?

Aetion, A Datavant Company Questions

News

Datavant Acquires NEA-Backed Aetion - citybiz

Datavant Acquires NEA-Backed Aetion citybiz

NEC Orchestrating Future Fund invests in Aetion, a U.S.-based provider of healthcare analytics platforms - NEC Global

NEC Orchestrating Future Fund invests in Aetion, a U.S.-based provider of healthcare analytics platforms NEC Global

NEC Orchestrating Future Fund Announces Strategic Investment in Aetion - PR Newswire

NEC Orchestrating Future Fund Announces Strategic Investment in Aetion PR Newswire

Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data - Lelezard

Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data Lelezard

Datavant to acquire real-world evidence company Aetion to boost its life sciences business - Fierce Healthcare

Datavant to acquire real-world evidence company Aetion to boost its life sciences business Fierce Healthcare

Aetion Appoints Jeremy Rassen as CEO - citybiz

Aetion Appoints Jeremy Rassen as CEO citybiz

Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer - PR Newswire

Aetion Launches Barcelona Technology Hub and Appoints Ken Watson as Chief Technology Officer PR Newswire

Aetion Named Leader in CB Insights' Synthetic Patient Data Market Report - PR Newswire

Aetion Named Leader in CB Insights' Synthetic Patient Data Market Report PR Newswire

Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe - PR Newswire

Aetion and Cegedim Health Data Announce Long-Term Partnership to Expand Real-World Evidence Research in Europe PR Newswire

Aetion Closes $110M Series C Funding Round Led by Warburg Pincus - PR Newswire

Aetion Closes $110M Series C Funding Round Led by Warburg Pincus PR Newswire

Aetion acquires synthetic data trailblazer Replica Analytics - PR Newswire

Aetion acquires synthetic data trailblazer Replica Analytics PR Newswire

Horizon Healthcare Services, Inc., Partners with Aetion to Improve Treatment Pathways Using Predictive Modeling and Machine Learning - PR Newswire

Horizon Healthcare Services, Inc., Partners with Aetion to Improve Treatment Pathways Using Predictive Modeling and Machine Learning PR Newswire

TREAT-NMD, a Leading Global NeuroMuscular Diseases Registry Network, and Aetion Announce Partnership on Real-World Evidence - PR Newswire

TREAT-NMD, a Leading Global NeuroMuscular Diseases Registry Network, and Aetion Announce Partnership on Real-World Evidence PR Newswire

Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization - PR Newswire

Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization PR Newswire

Aetion-HealthVerity partnership: More data sources, faster evidence generation - PR Newswire

Aetion-HealthVerity partnership: More data sources, faster evidence generation PR Newswire

Aetion Announces Partnership with the U.S. Food & Drug Administration and Brigham and Women's Hospital/Harvard Medical School to Integrate Real-World Evidence into Regulatory Decision-Making - PR Newswire

Aetion Announces Partnership with the U.S. Food & Drug Administration and Brigham and Women's Hospital/Harvard Medical School to Integrate Real-World Evidence into Regulatory Decision-Making PR Newswire

UCB and Aetion Announce Agreement to Enhance Real-World Evidence Generation to Advance Value-Based Contracts - PR Newswire

UCB and Aetion Announce Agreement to Enhance Real-World Evidence Generation to Advance Value-Based Contracts PR Newswire

Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe - PR Newswire

Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe PR Newswire

A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses - Wiley

A Structured Process to Identify Fit-for-Purpose Study Design and Data to Generate Valid and Transparent Real-World Evidence for Regulatory Uses Wiley

The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework - Wiley

The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework Wiley

Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer's Disease - Business Wire

Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer's Disease Business Wire

Q&A: Datavant on its acquisition of Aetion - Mobi Health News

Q&A: Datavant on its acquisition of Aetion Mobi Health News

Aetion Announces Leadership Changes - PR Newswire

Aetion Announces Leadership Changes PR Newswire

Transferability of real-world data across borders for regulatory and health technology assessment decision-making - Frontiers

Transferability of real-world data across borders for regulatory and health technology assessment decision-making Frontiers

Datavant to Acquire Real-World Evidence Platform Aetion - HIT Consultant

Datavant to Acquire Real-World Evidence Platform Aetion HIT Consultant

Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting - Wiley Online Library

Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting Wiley Online Library

Datavant: Acquisition Of Aetion Completed - Pulse 2.0

Datavant: Acquisition Of Aetion Completed Pulse 2.0

Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team - Endpoints News

Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team Endpoints News

Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity - medRxiv

Use of an EHR to inform an administrative data algorithm to categorize inpatient COVID-19 severity medRxiv

Datavant, Aetion merger creates real-world data force - pharmaphorum

Datavant, Aetion merger creates real-world data force pharmaphorum

Aetion raises $36m to develop drug efficacy analysis platform - Clinical Trials Arena

Aetion raises $36m to develop drug efficacy analysis platform Clinical Trials Arena

Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data - medRxiv

Duration of Protection Against SARS-CoV-2 Reinfection and Associated Risk of Reinfection Assessed with Real-World Data medRxiv

Cognito Therapeutics, Aetion to partner on AI model that identifies AD patients - Healio

Cognito Therapeutics, Aetion to partner on AI model that identifies AD patients Healio

Aetion hauls in $110M series C to fuel global growth in real-world evidence space - Fierce Healthcare

Aetion hauls in $110M series C to fuel global growth in real-world evidence space Fierce Healthcare

Datavant's acquisition of Aetion values it at almost $400M - Axios

Datavant's acquisition of Aetion values it at almost $400M Axios

Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study - BMJ Open

Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study BMJ Open

Warburg Pincus invests USD110m in Aetion - Private Equity Wire

Warburg Pincus invests USD110m in Aetion Private Equity Wire

Real-world evidence platform developer Aetion nabs Amgen-backed $36M series B - Fierce Biotech

Real-world evidence platform developer Aetion nabs Amgen-backed $36M series B Fierce Biotech

Amgen helps Aetion ace series B round - - Global Corporate Venturing

Amgen helps Aetion ace series B round - Global Corporate Venturing

Former FDA Commissioner Gottlieb joins health startup Aetion's board of directors - Fierce Healthcare

Former FDA Commissioner Gottlieb joins health startup Aetion's board of directors Fierce Healthcare

Aetion Raises Another $27M To Empower the Health Care Industry With Real Big Data - AlleyWatch

Aetion Raises Another $27M To Empower the Health Care Industry With Real Big Data AlleyWatch

Sanofi, Aetion collaborate to advance regulatory submissions - MassDevice

Sanofi, Aetion collaborate to advance regulatory submissions MassDevice

AeAetion Raises $11.2M for Real-World Evidence Data Analytics Platform - HIT Consultant

AeAetion Raises $11.2M for Real-World Evidence Data Analytics Platform HIT Consultant

Transformative trends with real-world data from early access programmes - pharmaphorum

Transformative trends with real-world data from early access programmes pharmaphorum

Top Aetion, A Datavant Company Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant